Daily archive
Health - Friday, May 15, 2026
AI-generated daily summary plus top ranked stories from the day.
Health headlines for Friday, May 15, 2026
Health headlines for 2026-05-15 focused on 3 major developments: 1) STAT+: FDA drug center head Tracy Beth Høeg leaves as agency faces leadership vacuum (STAT News) 2) Why So Many Guys Are Obsessed With Testosterone (NYT Health) 3) STAT+: Takeda will pay $13.6 million to settle allegations it paid kickbacks to doctors (STAT News) Across these stories, coverage emphasized high-impact updates, policy shifts, and events with broad audience relevance. Together they provide a representative view of the day in health news before diving into each full report.
Why it matters: This snapshot shows where health attention concentrated on 2026-05-15, highlighting the themes, entities, and geographies that dominated publisher coverage. Because ranking blends freshness, engagement, and source diversity, it helps separate signal from noise. Use it as a quick daily briefing and then open the top stories for fuller context.
Key Points
3 highlights-
STAT+: FDA drug center head Tracy Beth Høeg leaves as agency faces leadership vacuum
Sources: #1 STAT News -
Why So Many Guys Are Obsessed With Testosterone
Sources: #2 NYT Health -
STAT+: Takeda will pay $13.6 million to settle allegations it paid kickbacks to doctors
Sources: #3 STAT News
Top 10 Stories
Ranked by daily score-
#1 Score 72STAT+: FDA drug center head Tracy Beth Høeg leaves as agency faces leadership vacuumThe acting director of the FDA’s drug center, Tracy Beth Høeg, is leaving the agency. The news come days after Commissioner Marty Makary handed in his resignation.
- #2 Score 69Why So Many Guys Are Obsessed With Testosterone
From the Trump administration to online influencers, the hormone is increasingly seen as the key to achieving a new male ideal.
-
#3 Score 55STAT+: Takeda will pay $13.6 million to settle allegations it paid kickbacks to doctorsTakeda Pharmaceuticals agreed to pay $13.6 million to settle allegations that it paid kickbacks to doctors to prescribe an antidepressant.
-
#4 Score 47How Worried Should We Be About Hantavirus?Our global health reporter, Apoorva Mandavilli, explains that there is no indication the hantavirus outbreak could turn into a pandemic — but also that the public might not be getting all of the details.
- #5 Score 46Is cannabis safe after 65? Stanford experts reveal 5 risks older adults should know
Cannabis use among older adults is rising fast, but today’s marijuana is far more potent than many people realize — and experts warn the risks may be underestimated. Stanford Medicine specialists say modern cannabis can increase the chances of heart problems, falls, memory issues, dangerous drug interactions, and even addiction, especially for people over 65.
-
#6 Score 42STAT+: Up and down the ladder: The latest comings and goingsFrom new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
-
#7 Score 37Opinion: First hantavirus, now Ebola: What two outbreaks reveal about global preparedness“Preparedness is not built during a crisis press conference or after a pathogen has already crossed borders,” writes Krutika Kuppalli.
- #8 Score 37Scientists discover vitamin B2 may help cancer cells survive
Scientists have uncovered a surprising dark side to vitamin B2: it may help cancer cells stay alive. The vitamin supports a cellular shield that protects tumors from ferroptosis, a form of programmed cell death linked to cancer suppression. In lab tests, researchers used a vitamin B2-like compound called roseoflavin to break down that protection and trigger cancer cell death.
-
#9 Score 34A new Ebola outbreak is confirmed in a remote Congo province, with 65 deaths recordedA new Ebola outbreak has been confirmed in Congo’s remote Ituri province, with 246 suspected cases and 65 deaths recorded so far.
- #10 Score 29The brain’s “feel good” chemical may be secretly fueling tinnitus
Scientists have uncovered evidence that serotonin — the same brain chemical boosted by many antidepressants — may actually worsen tinnitus. Using advanced light-based brain stimulation in mice, researchers identified a serotonin-driven circuit linked directly to tinnitus-like behavior. The findings may explain why some people experience louder ringing in their ears while taking SSRIs.